Since cidofovir excretion in the proximal tubule of kidney is mostly mediated via the human organic anion transporter-1 (hOAT-1), probenecid as a hOAT-1 inhibitor can reduce drug uptake into the proximal tubule epithelium and prevent or minimize AKI [86]. This evidence concerns the gene SLC22A6 and acute kidney injury.